Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Agmatine is a naturally occurring derivative of the amino acid arginine and has been investigated for its neuromodulatory properties, including potential effects on the dopaminergic system. Preclinical studies (mainly in animal models and in vitro experiments) suggest that agmatine can modulate dopamine release and receptor activity, possibly by interacting with imidazoline and α2-adrenergic receptors, as well as by inhibiting some enzymes involved in neurotransmitter metabolism. There is evidence that agmatine may influence dopamine signaling indirectly, potentially providing neuroprotective benefits and modulating behaviors related to dopamine, such as those involved in reward and addiction. However, the clinical evidence in humans is very limited. Most research to date has focused on agmatine’s roles in neuropathic pain, depression, and neuroprotection, with only indirect implications for dopamine-related health conditions. There are no robust human trials specifically demonstrating that agmatine supplementation significantly supports or enhances the dopamine system in healthy individuals or in those with dopamine-related disorders like Parkinson’s disease. Thus, while there is a scientific rationale and some preclinical support, the overall evidence remains preliminary and not definitive for this specific use. More clinical research is needed to clarify agmatine’s effects on the dopamine system in humans.

More about Agmatine
More about Dopamine

Other ingredients that support Dopamine

Other body systems supported by Agmatine

Products containing Agmatine